Is CING or CLYM more undervalued in 2026?

CirclFi compares Cingulate Inc. (CING) and Climb Bio, Inc. (CLYM) using 13 institutional-grade valuation models. CING has a Quality of Company score of 3.0/10 while CLYM scores 4.2/10.

Which is a better buy — CING or CLYM?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do CING and CLYM valuations compare?

CING at $4.16 and CLYM at $10.96 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

CING vs CLYM Valuation Comparison 2026 — Intrinsic Value Analysis

CING

Pharmaceutical Preparations

Cingulate Inc.

Quality

3.0

out of 10

Value Trap

LOW

Price

$4.16

Last close

Models

6/13

Active

CLYM

Pharmaceutical Preparations

Climb Bio, Inc.

Quality

4.2

out of 10

Value Trap

SAFE

Price

$10.96

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	CING Fair Value	CING Upside	CLYM Fair Value	CLYM Upside
Bayesian DCF	Intrinsic	$1.90	-54.3%	$2.90	-73.5%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$2.42	-41.8%	$1.93	-82.4%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for CING vs CLYM — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CING vs CLYM — Which Stock Is More Undervalued?

CLYM scores higher with a 4.2/10 quality rating vs CING's 3.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Cingulate Inc. (CING) and Climb Bio, Inc. (CLYM) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CING currently trades at $4.16 with a QOC of 3.0/10, while CLYM trades at $10.96 with a QOC of 4.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).